stoxline Quote Chart Rank Option Currency Glossary
  
Mainz Biomed B.V. (MYNZ)
0.535  -0.066 (-10.98%)    06-18 12:23
Open: 0.631
High: 0.64
Volume: 250,611
  
Pre. Close: 0.601
Low: 0.505
Market Cap: 12(M)
Technical analysis
2024-06-18 11:52:04 AM
Short term     
Mid term     
Targets 6-month :  0.95 1-year :  1.17
Resists First :  0.81 Second :  1
Pivot price 0.7
Supports First :  0.5 Second :  0.42
MAs MA(5) :  0.61 MA(20) :  0.68
MA(100) :  0.88 MA(250) :  1.94
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  7.8 D(3) :  15.3
RSI RSI(14): 36
52-week High :  5.01 Low :  0.5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MYNZ ] has closed below the lower bollinger band by 1.9%. Bollinger Bands are 41.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.64 - 0.64 0.64 - 0.65
Low: 0.58 - 0.59 0.59 - 0.59
Close: 0.59 - 0.6 0.6 - 0.61
Company Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Headline News

Fri, 14 Jun 2024
Critical Comparison: Mainz Biomed (MYNZ) versus Its Peers - Defense World

Tue, 04 Jun 2024
Mainz Biomed shares target halved, retains Buy rating on funding concerns By Investing.com - Investing.com

Fri, 31 May 2024
Mainz Biomed Announces AGM Success and Nasdaq Compliance Plan - TipRanks.com - TipRanks

Fri, 31 May 2024
Mainz Biomed Reports Results of 2024 Annual General Meeting - GlobeNewswire

Tue, 28 May 2024
Mainz Biomed (NASDAQ:MYNZ) Shares Up 1.6% - Defense World

Wed, 03 Aug 2022
Here's What Mainz Biomed B.V.'s (NASDAQ:MYNZ) Shareholder Ownership Structure Looks Like - Yahoo Australia

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 0 (M)
Shares Float 22 (M)
Held by Insiders 1.839e+007 (%)
Held by Institutions 21.6 (%)
Shares Short 302 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.607e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -3 %
Return on Assets (ttm) 68.7 %
Return on Equity (ttm) -93.5 %
Qtrly Rev. Growth 895480 %
Gross Profit (p.s.) 37
Sales Per Share -1010.67
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -22 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 1.03
Stock Dividends
Dividend 0
Forward Dividend 300860
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android